首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Survey of Willingness to Accept Chemotherapy among Elderly Malaysian Patients
【24h】

Survey of Willingness to Accept Chemotherapy among Elderly Malaysian Patients

机译:在马来西亚老年患者中接受化疗的意愿调查

获取原文
获取外文期刊封面目录资料

摘要

Background: The geriatric population in Malaysia is predicted to increase from 4% of the total population in 1998 to 9.8% by 2020, in parallel with developments in the socioeconomy. Cancer is expected to be a major medical issue among this population. However, the decision for treatment in Malaysia is always decided by the caregivers instead of the elderly patients themselves. Objective: The aim of the study was to assess the willingness to accept chemotherapy among elderly Malaysians. Materials and Methods: In this cross-sectional study, patients aged 60 and above from various clinics/wards were recruited. Those giving consent were interviewed using a questionnaire. Results: A total of 75 patients were recruited, 35 patients (47%) with a history of cancer. The median age was 73 years old. There were 29 Chinese (38.7%), 22 Indian (29.3%), 20 Malay (26.7%) and four other ethnicity patients. Some 83% and 73% of patients willing to accept strong and mild chemotherapy, respectively. Patients with cancer were more willing to accept strong and mild chemotherapy compared to the non-cancer group (88.6% vs 62.5%, P=0.005, 94% vs 80%, P=0.068). On sub-analysis, 71.4% and 42.9% of Chinese patients without a history of cancer were not willing to receive strong and mild chemotherapy, respectively. Conclusions: The majority of elderly patients in UMMC were willing to receive chemotherapy if they had cancer. Experience with previous treatment had positive influence on the willingness to undergo chemotherapy.
机译:背景:马来西亚的老年牧场人口预计将从1998年总人口的4%增加到2020年的9.8%,同时与社会经济的发展平行。预计癌症将成为这一人口中的主要医学问题。然而,马来西亚治疗的决定总是由护理人员决定,而不是老年患者自己决定。目的:该研究的目的是评估马来西亚老年人之间接受化疗的意愿。材料和方法:在这种横断面研究中,招募了60岁及以上患者的各种诊所/病房。那些同意的人使用调查问卷进行了采访。结果:招募了75名患者,35名患者(47%),癌症史。中位年龄为73岁。有29名中文(38.7%),22名印度(29.3%),20名马来(26.7%)和其他四名种族患者。大约83%和73%的患者分别接受强烈和温和的化疗。与非癌症组相比,癌症患者更愿意接受强烈和温和的化疗(88.6%vs 62.5%,p = 0.005,94%,vs 80%,p = 0.068)。在分析中,71.4%和42.9%的中国患者没有癌症史的患者分别不愿接受强烈和温和的化疗。结论:如果患有癌症,UMMC的大多数老年患者都愿意接受化疗。以前治疗的经验对接受化学疗法的意愿具有积极的影响。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号